by lythamcorp | Oct 28, 2024 | Healthcare, Shuttle Pharmaceuticals
GAITHERSBURG, Md., Oct. 28, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation...
by lythamcorp | Oct 28, 2024 | Healthcare, Shuttle Pharmaceuticals
GAITHERSBURG, Md., Oct. 28, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (“RT”),...
by lythamcorp | Oct 28, 2024 | ChromaDex News, Consumer
LOS ANGELES – ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announced that it has rescheduled its previously announced conference call to Thursday, October 31, 2024 at...
by lythamcorp | Oct 28, 2024 | Mogo, MOGO News, Technology
VANCOUVER, British Columbia – Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) (“Mogo” or the “Company”), a digital wealth and payments business, today announced it will hold a conference call and webcast to discuss its Q3 2024 financial results on...
by lythamcorp | Oct 25, 2024 | Aurora Spine Corporation, Aurora Spine News, Healthcare
CARLSBAD, Calif., Oct. 25, 2024 — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it...